ATE470154T1 - Verfahren zur bewertung von insulinresistenz - Google Patents

Verfahren zur bewertung von insulinresistenz

Info

Publication number
ATE470154T1
ATE470154T1 AT05787492T AT05787492T ATE470154T1 AT E470154 T1 ATE470154 T1 AT E470154T1 AT 05787492 T AT05787492 T AT 05787492T AT 05787492 T AT05787492 T AT 05787492T AT E470154 T1 ATE470154 T1 AT E470154T1
Authority
AT
Austria
Prior art keywords
insulin resistance
parameter
assessing insulin
fasting
evaluating
Prior art date
Application number
AT05787492T
Other languages
English (en)
Inventor
Junichi Amata
Shigeo Takahashi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE470154T1 publication Critical patent/ATE470154T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
AT05787492T 2004-09-28 2005-09-28 Verfahren zur bewertung von insulinresistenz ATE470154T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004281680A JP4210855B2 (ja) 2004-09-28 2004-09-28 インスリン抵抗性の評価方法
PCT/JP2005/017820 WO2006035804A1 (ja) 2004-09-28 2005-09-28 インスリン抵抗性の評価方法

Publications (1)

Publication Number Publication Date
ATE470154T1 true ATE470154T1 (de) 2010-06-15

Family

ID=36118950

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05787492T ATE470154T1 (de) 2004-09-28 2005-09-28 Verfahren zur bewertung von insulinresistenz

Country Status (8)

Country Link
US (1) US7592180B2 (de)
EP (1) EP1804063B1 (de)
JP (1) JP4210855B2 (de)
KR (1) KR100981831B1 (de)
AT (1) ATE470154T1 (de)
DE (1) DE602005021669D1 (de)
ES (1) ES2346767T3 (de)
WO (1) WO2006035804A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5393798B2 (ja) * 2008-10-20 2014-01-22 リポサイエンス，インコーポレイテッド リポタンパク質インスリン抵抗性指数、ならびに同一物を生成するための関連する方法、システムおよびコンピュータプログラム
JPWO2010103585A1 (ja) * 2009-03-08 2012-09-10 横田　充弘 メタボリック症候群又はその構成疾患の評価法
WO2017161105A1 (en) * 2016-03-16 2017-09-21 True Health Ip Llc Methods of treating impaired glucose tolerance and/or decreased insulin secretion
US11158413B2 (en) * 2018-04-23 2021-10-26 Medtronic Minimed, Inc. Personalized closed loop medication delivery system that utilizes a digital twin of the patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323296B2 (en) * 2004-10-01 2008-01-29 Yuanhong Ma Method and index for diagnosing insulin resistance

Also Published As

Publication number Publication date
JP2006098100A (ja) 2006-04-13
US7592180B2 (en) 2009-09-22
JP4210855B2 (ja) 2009-01-21
EP1804063B1 (de) 2010-06-02
ES2346767T3 (es) 2010-10-20
WO2006035804A1 (ja) 2006-04-06
KR20070058670A (ko) 2007-06-08
DE602005021669D1 (de) 2010-07-15
US20080066526A1 (en) 2008-03-20
KR100981831B1 (ko) 2010-09-13
EP1804063A4 (de) 2008-05-28
EP1804063A1 (de) 2007-07-04

Similar Documents

Publication Publication Date Title
DE602006003787D1 (de) Bestimmung der tatsächlichen Zeit, die ein Prozessor bei der Ausführung eines Codeteiles aufwendet
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
DE60218268D1 (de) Verfahren zur Analyse der Blutkoagluationsreaktion
CA2726071A1 (en) Blood glucose monitoring device
ATE423980T1 (de) Verfahren zur vergrösserung der positionsverfügbarkeit
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
ATE432470T1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
BRPI0700149A (pt) aparelho para a avaliação do estado hemodinámico do paciente usando a interação coração-pulmão
ATE482394T1 (de) Verfahren, vorrichtung und programm zur bewertung der immunität sowie datenaufzeichnungsmedium mit darin gespeichertem immunitätsbewertungsprogramm
DE602006011956D1 (de) Verfahren und vorrichtung zur erkennung eines fehlerzustands und zur behebung danach unter verwendung von benutzerkontextinformationen
ATE426175T1 (de) Verfahren zur standardisierung von gerinnungstesten
DE602005025940D1 (de) Verfahren zum testen endokriner substanz in proben
DE602005007817D1 (de) Analyse-Verfahren unter Verwendung von abgeschwächter Totalreflektion
ATE470154T1 (de) Verfahren zur bewertung von insulinresistenz
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
FI20075908A0 (fi) Elektroniikkalaite ja menetelmä
ATE367764T1 (de) Vorrichtung zur messung der konzentration eines analyts in einer augenflüssigkeit
ATE438149T1 (de) Verfahren und vorrichtung zur evaluierung der eigenschaften einer webseite
DK1549208T3 (da) Fremgangmåde til omdannelse af venøse blodværdier til arterielle blodværdier, system til anvendelse af fremgangsmåden
WO2009141352A3 (en) Risk analysis in patients with and without metabolic syndrome
ATE306659T1 (de) Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode
DE602005007818D1 (de) Analysevorrichtung unter Verwendung von abgeschwächter Totalreflektion
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
WO2005108649A3 (en) One-point recalibration method for reducing error in concentration measurements for an electrolytic solution

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties